Caxton Associates LP Insmed Inc Transaction History

Caxton Associates LP

  • $3.12 Billion
  • Q4 2024

A detailed history of Caxton Associates LP transactions in Insmed Inc stock. As of the latest transaction made, Caxton Associates LP holds 7,678 shares of INSM stock, worth $1.48 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
7,678
Previous 8,269 7.15%
Holding current value
$1.48 Million
Previous $603,000 12.11%
% of portfolio
0.02%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$66.29 - $76.63 $39,177 - $45,288
-591 Reduced 7.15%
7,678 $530,000
Q3 2024

Nov 14, 2024
BUY
$62.0 - $79.01 $512,678 - $653,333
8,269 New
8,269 $603,000

About INSMED Inc

INSM Quotes by TradingView
  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $26.2B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Caxton Associates LP Portfolio

Follow Caxton Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Caxton Associates LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email